Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics (2024)
- Authors:
- USP affiliated authors: SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.3389/fpsyt.2024.1485337
- Subjects: FÁRMACOS PSICOTRÓPICOS; ALUCINOGÊNICOS; NEUROTRANSMISSORES; SEROTONINA
- Keywords: Dimethyltryptamine (DMT); Ayahuasca; Psychedelics; Hallucinogen; Neuroplasticity; Sigma-1 receptor; Serotonin 2A (5HT2A) receptor; Pharmacology
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Psychiatry
- ISSN: 1664-0640
- Volume/Número/Paginação/Ano: v. 15, art. 1485337, p. 1-8, 2024
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
CHAVES, Cristiano et al. Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics. Frontiers in Psychiatry, v. 15, p. 1-8, 2024Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2024.1485337. Acesso em: 19 mar. 2026. -
APA
Chaves, C., Santos, R. G. dos, Dursun, S. M., Tusconi, M., Carta, M. G., Brietzke, E., & Hallak, J. E. C. (2024). Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics. Frontiers in Psychiatry, 15, 1-8. doi:10.3389/fpsyt.2024.1485337 -
NLM
Chaves C, Santos RG dos, Dursun SM, Tusconi M, Carta MG, Brietzke E, Hallak JEC. Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics [Internet]. Frontiers in Psychiatry. 2024 ; 15 1-8.[citado 2026 mar. 19 ] Available from: https://doi.org/10.3389/fpsyt.2024.1485337 -
Vancouver
Chaves C, Santos RG dos, Dursun SM, Tusconi M, Carta MG, Brietzke E, Hallak JEC. Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics [Internet]. Frontiers in Psychiatry. 2024 ; 15 1-8.[citado 2026 mar. 19 ] Available from: https://doi.org/10.3389/fpsyt.2024.1485337 - Psychedelic medicines in major depression: progress and future challenges
- Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial]
- Hallucinations and hallucinogens: psychopathology or wisdom?
- Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences
- Ayahuasca-enhanced extinction of fear behaviour: role ofinfralimbic cortex 5-HT 2A and 5-HT 1A receptors
- Psychedelics in psychiatry
- Acute psychological adverse reactions in first-time ritual ayahuasca users: a prospective case series
- Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
- Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: evidence and mechanisms of action
- Effects of ayahuasca on mental health and quality of life in naïve users: a longitudinal and cross-sectional study combination
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003249584.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
